PUBLISHER: IMARC | PRODUCT CODE: 1541627
PUBLISHER: IMARC | PRODUCT CODE: 1541627
The global artificial insemination market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032. Increasing infertility rates, rapid lifestyle changes, and escalating prevalence of medical conditions represent some of the key factors driving the market.
Artificial insemination is a process of fertilization that involves the placement of sperm directly into the female reproductive system through medical procedures. It typically involves the use of either fresh or frozen sperm and can be done in a variety of ways, including intracervical, intrauterine, or intravaginal methods. The components of artificial insemination include semen collection, semen processing, and semen placement. Artificial insemination offers increased chances of conception, reduced risk of sexually transmitted infections (STIs), and the ability to use donor sperm in cases of male infertility. Additionally, as compared to in vitro fertilization (IVF), artificial insemination is minimally invasive (MI) and cost-effective. Currently, there are two primary types of the procedure, including homologous and heterologous. Homologous insemination involves using the male partner's sperm to fertilize the female partner's egg, while heterologous insemination involves using donor sperm to fertilize the female partner's egg.
The increasing infertility rates and the need for assisted reproductive technologies (ART) are some of the key factors boosting the market growth. The rapid lifestyle changes and escalating prevalence of medical conditions, such as polycystic ovary syndrome (PCOS) and endometriosis, have surged the demand for artificial insemination procedures, further accelerating the market growth. This is further supported by the growing acceptance and accessibility of artificial insemination in emerging economies. Moreover, various technological advancements, such as the development of improved techniques for sperm and egg selection, cryopreservation, and pre-implantation genetic testing, are propelling the market growth. Besides this, the availability of donor sperm and donor eggs, the rising popularity of same-sex marriage and LGBT parenting, and the improving healthcare infrastructure are factors expected to drive the market growth. Furthermore, the presence of favorable regulations, the growing awareness and education campaigns about infertility and artificial insemination, and the escalating demand for personalized and customized artificial insemination procedures are fueling the market growth. Other factors, such as the increasing number of clinics and healthcare facilities offering artificial insemination services, the availability of insurance coverage for the procedure, and the surging trend of delaying childbirth and pursuing career goals, are positively supporting the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial insemination market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, source type and end use.
Intrauterine
Intracervical
Intravaginal
Intratubal
The report has provided a detailed breakup and analysis of the global artificial insemination market based on the type. This includes intrauterine, intracervical, intravaginal, and intratubal. According to the report, the intrauterine segment dominates the market.
AIH-Husband
AID-Donor
The report has provided a detailed breakup and analysis of the global artificial insemination market based on the source type. This includes AIH-husband and AID-donor.